Wedbush Initiates Coverage On Sabra Health Care REIT with Outperform Rating, Announces Price Target of $16
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Richard Anderson has initiated coverage on Sabra Health Care REIT (NASDAQ:SBRA) with an Outperform rating and a price target of $16.
October 03, 2023 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sabra Health Care REIT has been given an Outperform rating by Wedbush with a price target of $16.
The Outperform rating from Wedbush indicates that the analyst expects Sabra Health Care REIT to do better than the market average. This positive outlook, coupled with a price target of $16, suggests potential upside for the stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100